Page last updated: 2024-08-26

selenium and gefitinib

selenium has been researched along with gefitinib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Schiller, JH1
Chang, CL; Chiou, TJ; Chuang, SE; Hsia, S; Hu, MH; Lai, GM; Liao, CH; Liu, YR; Tsai, WL; Tzeng, YT; Wang, LM; Whang-Peng, J; Yao, CJ1
Hsia, S; Wang, H; Wu, CJ; Wu, TH1
Chen, PC; Guo, CH; Hsia, S; Lee, SY; Li, WC; Peng, CL1

Reviews

1 review(s) available for selenium and gefitinib

ArticleYear
Adjuvant systemic therapies in early-stage non-small-cell lung cancer.
    Clinical lung cancer, 2003, Volume: 5 Suppl 1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Chemotherapy, Adjuvant; Drug Resistance; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Neoadjuvant Therapy; Neoplasm Metastasis; Prognosis; Protein-Tyrosine Kinases; Quinazolines; Radiotherapy, Adjuvant; Selenium; Survival Analysis

2003

Trials

1 trial(s) available for selenium and gefitinib

ArticleYear
Adjuvant systemic therapies in early-stage non-small-cell lung cancer.
    Clinical lung cancer, 2003, Volume: 5 Suppl 1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Chemotherapy, Adjuvant; Drug Resistance; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Neoadjuvant Therapy; Neoplasm Metastasis; Prognosis; Protein-Tyrosine Kinases; Quinazolines; Radiotherapy, Adjuvant; Selenium; Survival Analysis

2003

Other Studies

3 other study(ies) available for selenium and gefitinib

ArticleYear
Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells.
    Marine drugs, 2020, Jul-29, Volume: 18, Issue:8

    Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Epithelial-Mesenchymal Transition; Fatty Acids, Omega-3; Gefitinib; Humans; Lung Neoplasms; Neoplastic Stem Cells; Selenium

2020
Fish Oil, Se Yeast, and Micronutrient-Enriched Nutrition as Adjuvant Treatment during Target Therapy in a Murine Model of Lung Cancer.
    Marine drugs, 2021, May-04, Volume: 19, Issue:5

    Topics: Administration, Oral; Animals; Apoptosis; Cachexia; Carcinoma, Lewis Lung; Cell Line, Tumor; Chemotherapy, Adjuvant; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fish Oils; Gefitinib; Inflammation; Male; Mice, Inbred C57BL; Micronutrients; Neoplasm Metastasis; Oxidation-Reduction; Protein Kinase Inhibitors; Selenium; Sunitinib; Tumor Burden; Yeast, Dried

2021
Targeting EGFR in Combination with Nutritional Supplements on Antitumor Efficacy in a Lung Cancer Mouse Model.
    Marine drugs, 2022, Nov-29, Volume: 20, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Dietary Supplements; ErbB Receptors; Erlotinib Hydrochloride; Fish Oils; Gefitinib; Glycogen Synthase Kinase 3 beta; Mice; Protein Kinase Inhibitors; Selenium

2022